Mediterranean diet study for men on prostate cancer active surveillance
Part of Cancer, Kidney & urinary clinical trials.
This trial studies how different controlled versions of a Mediterranean-style diet may affect prostate cancer-related metabolism in men choosing active surveillance. It may help participants understand whether diet changes influence markers linked to prostate cancer activity, while keeping them on a monitored care plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man age 18 or older
- Your doctor thinks you may have prostate cancer, and you have NOT had prostate cancer or hormone treatment before
- You are planning “active surveillance,” meaning you’ll monitor with repeat testing (including biopsy if needed)
- You can and are willing to follow the study’s diet plan and avoid other similar diets or supplements that could interfere
- You must be able to do transperineal prostate biopsies if your biopsy needs to be done
- Basic lab numbers and organ function must be within required ranges (blood counts, liver tests, and kidney function)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medically designed Mediterranean diet can help men before prostate cancer surgery. You would eat special foods and be monitored closely to see how the diet affects your health and recovery.
This study tests whether a Mediterranean diet can help men with prostate cancer. You'll receive guidance on following this diet to see if it improves your health.
This trial follows men with prostate cancer who choose “active surveillance” instead of immediate treatment. It tests whether careful tracking (including patient reports) can help manage cancer over time and guide decision-making.
This study follows men with low-risk prostate cancer who choose active surveillance (watching closely instead of immediate treatment). It aims to better track which monitoring results stay reassuring over time, and when treatment might be needed.
This study tests whether watching low-risk prostate cancer closely (instead of treating right away) is safe. It may help some people avoid early treatments and their side effects while still keeping a close eye on the cancer.
This trial studies how well “active surveillance” works for men with prostate cancer who are considered higher risk because of family history or genetics. It aims to safely monitor the cancer and decide the best timing for treatment if needed, while tracking side effects and follow-up success.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.